Breaking

Ukraine–Russia at a crossroads: How the war evolved in 2025 and what comes next
Congress blocks Obamacare subsidies after shutdown fight, premiums set to surge
Putin residence drone attack dismissed as implausible as Ukraine accusations mount
LaFleur Minerals Closes Upsized, Fully Subscribed LIFE Offering and FT Offering
Top 5 Small-cap Biotech Stocks of 2025
Sankamap Provides an Update on Status of Late Filing of Financial Statements
Zelenskyy says peace deal is close after Trump meeting but territory remains sticking point
Eric Adams says Biden DOJ used ‘lawfare’ against him, compares treatment to Trump

Business
Politics
Investing
World
Search for:

Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

LaFleur Minerals Closes Upsized, Fully Subscribed LIFE Offering and FT Offering

December 31, 2025

Top 5 Small-cap Biotech Stocks of 2025

December 31, 2025

Sankamap Provides an Update on Status of Late Filing of Financial Statements

December 31, 2025

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,184)
- Investing (4,472)
- Politics (5,961)
- World (4,283)

Disclaimer: MicroStocksSecrets.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 microstockssecrets.com | All Rights Reserved

Top

Business
Politics
Investing
World

Type above and press Enter to search. Press Esc to cancel.